Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SNYR
SNYR logo

SNYR Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
0.533
Open
0.533
VWAP
0.49
Vol
2.03M
Mkt Cap
6.22M
Low
0.422
Amount
987.92K
EV/EBITDA(TTM)
--
Total Shares
11.30M
EV
30.41M
EV/OCF(TTM)
--
P/S(TTM)
0.18
Synergy CHC Corp. is a provider of consumer healthcare, beauty, and lifestyle products. The Company's brand portfolio includes FOCUSfactor and Flat Tummy. FOCUSfactor is a clinically studied brain health supplement and functional beverage line. Flat Tummy is a lifestyle brand that provides a suite of nutritional products to help women achieve their weight management goals. It has six additional, non-core brands are Hand MD is a complete hand-care brand to help maintain clean and healthy hands while reducing the signs of aging; Perfekt Beauty is in beauty line of products for the eyes, lips, brows, cheeks and skin; Sneaky Vaunt is in lingerie brand with a line of women’s shapewear, bralettes and panties; The Queen Pegasus is in eyelash enhancement products for longer, thicker, natural lashes; Neuragen is in fast-acting topical treatments for neuropathic (nerve) pain, and UrgentRx is in line of fast-acting, portable, powdered over-the-counter medications.
Show More

Events Timeline

(ET)
2026-04-01
09:20:00
Company Q4 Revenue Falls to $6.07M
select
2026-01-27 (ET)
2026-01-27
08:10:00
Synergy CHC Expands FOCUSfactor Product Line in Canada
select
2025-12-16 (ET)
2025-12-16
08:10:00
Synergy CHC Appoints Pedro Colmenares as Sales & Marketing Director for Mexico & Latin America
select
2025-12-15 (ET)
2025-12-15
08:10:00
Synergy CHC Announces New Partnerships with Beverage Companies
select
2025-11-18 (ET)
2025-11-18
09:30:20
Synergy CHC Welcomes Five New Direct Store Delivery Partners
select
2025-11-13 (ET)
2025-11-13
08:12:41
Synergy CHC Announces Q3 Earnings Per Share of 1 Cent Compared to 11 Cents Last Year
select
2025-11-05 (ET)
2025-11-05
08:15:20
Synergy CHC Forms Strategic Distribution Alliance with C&M Sales
select
2025-10-22 (ET)
2025-10-22
08:08:52
Synergy CHC Reveals New Retail Authorizations and Distribution Collaboration
select

News

seekingalpha
9.5
04-02seekingalpha
Synergy CHC Reports FY 2025 Earnings Results
  • Poor Earnings Performance: Synergy CHC reported a FY 2025 GAAP EPS of -$1.27, indicating significant challenges in profitability that could undermine investor confidence and affect stock performance.
  • Revenue Decline: The company reported revenue of $30.38 million, a 12.8% year-over-year decrease, reflecting weak market demand and intensified competition, which may lead to uncertainties in future growth prospects.
  • Quarterly Earnings Call Insights: During the Q4 2025 earnings call, management is expected to discuss specific factors contributing to the revenue decline and outline strategies to restore market confidence and improve performance.
  • Historical Financial Data: Historical financial data for Synergy CHC indicates that ongoing losses and declining revenues may pose a threat to the company's long-term sustainability, prompting investors to closely monitor future financial performance and strategic adjustments.
Yahoo Finance
9.5
04-01Yahoo Finance
Synergy CHC Corp Reports Significant Q4 Losses Amid Revenue Decline
  • Significant Revenue Decline: Synergy CHC Corp reported a Q4 net revenue of $6.07 million, a 41% decrease year-over-year, primarily due to a $2.5 million revenue reversal from the termination of an international license agreement, highlighting the company's vulnerability in international markets and reliance on revenue sources.
  • Gross Margin Drop: The gross margin for Q4 fell to 36.6%, down from 63.3% in the same quarter last year, indicating severe challenges to profitability due to inventory write-offs and the impact of the license agreement termination, which may affect future investor confidence.
  • Surge in Operating Expenses: Operating expenses surged to $15.53 million in Q4, up from $5.14 million in the prior year, driven by one-time items such as bad debt allowances and prepaid media credit write-offs, further exacerbating the company's financial burden.
  • Widening Net Loss: The company reported a net loss of $14.82 million for Q4, a significant decline from a net income of $105,700 in the same quarter of the previous year, reflecting increased pressure in market competition and deteriorating financial health, which may raise investor concerns about future growth.
Newsfilter
9.5
03-30Newsfilter
Synergy CHC Corp. Updates Q4 and Full Year 2025 Financial Results Release Date
  • Financial Reporting Schedule: Synergy CHC Corp. will release its fourth quarter and full year financial results for the period ending December 31, 2025, on April 1, 2026, before market open, ensuring timely access to critical financial information for investors.
  • Conference Call Details: The company's CEO Jack Ross and CFO Jaime Fickett will host a conference call at 9:00 a.m. ET to provide detailed insights into the financial results, enhancing communication with investors.
  • Webcast Availability: The conference call will be available via a live webcast on the company's Investor Relations section, allowing investors who cannot dial in to participate, thereby improving information transparency.
  • Brand Market Performance: Synergy's brands, FOCUSfactor® and Flat Tummy®, continue to grow in major retailers across the U.S., Canada, Mexico, and the U.K., demonstrating the company's strong competitive position in the health and wellness product market.
Yahoo Finance
1.0
02-21Yahoo Finance
New Show to Air Tonight on Bloomberg Television
  • Global Broadcast Expansion: New to The Street's latest episode will air tonight at 6:30 PM EST on Bloomberg Television, extending its reach to the U.S., MENA, and Latin America, thereby enhancing international investor engagement and broadening its audience base.
  • Biotech Advancements: BioVie Inc. is advancing a clinical trial for Parkinson's disease with 60 patients enrolled, expecting topline data in May 2026, which could significantly bolster its market position in the biopharmaceutical sector if successful.
  • Obstructive Sleep Apnea Solutions: Vivos Therapeutics Inc.'s FDA-cleared non-surgical oral appliance aims to provide a long-term solution for the estimated one billion people affected by OSA globally, with strategic growth initiatives targeting direct-to-patient markets.
  • Virtual Reality Market Growth: Virtuix Holdings Inc.'s Omni One platform has reported a 138% year-over-year growth in the gaming and fitness sectors, with production capacity supporting potential annual revenues of up to $100 million, indicating strong demand in both consumer and defense markets.
Yahoo Finance
8.5
02-07Yahoo Finance
New Show Airing on Bloomberg Television
  • Rich Program Content: Tonight's airing of 'New to The Street' on Bloomberg Television will showcase Virtuix's immersive technology platform, highlighting its rapid growth in consumer and defense markets, which is expected to attract a wide audience.
  • International Expansion Update: YY Group will provide updates on its international expansion in Hong Kong, UAE, and Southeast Asia, showcasing AI-enabled workforce automation and strong revenue momentum, indicating its competitiveness in the premium client market.
  • Strategic Acquisition Discussion: Roadzen's leadership will discuss its strategic acquisition plans and the scaling of its AI-driven auto insurance and claims ecosystem, demonstrating its innovative capabilities and market potential in the insurance industry.
  • Fintech Strategy: Alphaton Capital will outline its fintech-driven investment strategy and capital markets positioning in an interview filmed at the New York Stock Exchange, enhancing its credibility and appeal among global investors.
Yahoo Finance
1.0
01-17Yahoo Finance
New to The Street Broadcasts Show #716 Featuring SDST and Others
  • Broadcast Timing: New to The Street will air Show #716 tonight at 6:30 PM Eastern Time on Bloomberg Television, enhancing its influence in the business media landscape by showcasing various public companies.
  • Company Highlights: The episode will spotlight Stardust Power Inc. (NASDAQ:SDST), BioVie Inc. (NASDAQ:BIVI), and Roadzen Inc. (NASDAQ:RDZN), showcasing innovations in critical minerals, biotechnology, and AI-driven mobility and insurance solutions, aimed at attracting investor interest.
  • Celebrity Features: The show will also include special segments with Kelsey Grammer discussing his new book KAREN and Andrew Shaw introducing his nonprofit 250DAYS.ORG, emphasizing the importance of mental health awareness and recovery, thereby enhancing the program's social impact.
  • International Expansion Plans: New to The Street plans to launch its international version in the MENA region on January 24, 2026, further expanding its global reach, while also preparing to launch the Spanish-language platform Nuevo En La Calle, showcasing its diversified media strategy.
Wall Street analysts forecast SNYR stock price to rise
2 Analyst Rating
Wall Street analysts forecast SNYR stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
5.00
Averages
6.00
High
7.00
Current: 0.000
sliders
Low
5.00
Averages
6.00
High
7.00
Ascendiant
Edward Woo
Buy
initiated
$5
AI Analysis
2026-02-02
Reason
Ascendiant
Edward Woo
Price Target
$5
AI Analysis
2026-02-02
initiated
Buy
Reason
Ascendiant analyst Edward Woo initiated coverage of Synergy CHC with a Buy rating and $5 price target. Synergy provides consumer health care, beauty, and lifestyle products, the analyst tells investors in a research note. The firm sees large market opportunities for the company's brain health supplement FOCUSfactor.
Roth Capital
Sean McGowan
Buy
downgrade
$10 -> $7
2025-11-14
Reason
Roth Capital
Sean McGowan
Price Target
$10 -> $7
2025-11-14
downgrade
Buy
Reason
Roth Capital analyst Sean McGowan lowered the firm's price target on Synergy CHC to $7 from $10 and keeps a Buy rating on the shares. The company made good progress during Q3, broadening its distribution footprint for both supplements and beverages and continuing to expand geographically, though its results came up short of expectations due in part to cash being tight prior to the company's recent equity raise, the analyst tells investors in a research note. Roth adds however that Synergy now has the capital needed to post significant growth in 2026.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for SNYR
Unlock Now

Valuation Metrics

The current forward P/E ratio for Synergy CHC Corp (SNYR.O) is 4.19, compared to its 5-year average forward P/E of 1.44. For a more detailed relative valuation and DCF analysis to assess Synergy CHC Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
1.44
Current PE
4.19
Overvalued PE
4.02
Undervalued PE
-1.14

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
3.78
Current EV/EBITDA
-0.00
Overvalued EV/EBITDA
6.06
Undervalued EV/EBITDA
1.51

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.41
Current PS
0.12
Overvalued PS
0.65
Undervalued PS
0.18

Financials

AI Analysis
Annual
Quarterly

Whales Holding SNYR

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Synergy CHC Corp (SNYR) stock price today?

The current price of SNYR is 0.5069 USD — it has decreased -7.82

What is Synergy CHC Corp (SNYR)'s business?

Synergy CHC Corp. is a provider of consumer healthcare, beauty, and lifestyle products. The Company's brand portfolio includes FOCUSfactor and Flat Tummy. FOCUSfactor is a clinically studied brain health supplement and functional beverage line. Flat Tummy is a lifestyle brand that provides a suite of nutritional products to help women achieve their weight management goals. It has six additional, non-core brands are Hand MD is a complete hand-care brand to help maintain clean and healthy hands while reducing the signs of aging; Perfekt Beauty is in beauty line of products for the eyes, lips, brows, cheeks and skin; Sneaky Vaunt is in lingerie brand with a line of women’s shapewear, bralettes and panties; The Queen Pegasus is in eyelash enhancement products for longer, thicker, natural lashes; Neuragen is in fast-acting topical treatments for neuropathic (nerve) pain, and UrgentRx is in line of fast-acting, portable, powdered over-the-counter medications.

What is the price predicton of SNYR Stock?

Wall Street analysts forecast SNYR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SNYR is6.00 USD with a low forecast of 5.00 USD and a high forecast of 7.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Synergy CHC Corp (SNYR)'s revenue for the last quarter?

Synergy CHC Corp revenue for the last quarter amounts to 6.07M USD, decreased -40.95

What is Synergy CHC Corp (SNYR)'s earnings per share (EPS) for the last quarter?

Synergy CHC Corp. EPS for the last quarter amounts to -1.31 USD, decreased -13200.00

How many employees does Synergy CHC Corp (SNYR). have?

Synergy CHC Corp (SNYR) has 28 emplpoyees as of April 16 2026.

What is Synergy CHC Corp (SNYR) market cap?

Today SNYR has the market capitalization of 6.22M USD.